Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Menopausal Hormone Therapy Use and Risk of Invasive Colon Cancer
Link ID 23112
Title Menopausal Hormone Therapy Use and Risk of Invasive Colon Cancer
Url http://www.medscape.com/viewarticle/717170?src=rss
Description Does hormone replacement therapy in menopausal women decrease the risk of invasive colon cancer? American Journal of Epidemiology
Category Articles > Internal Medicine
Keywords
Date Mar 10, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Internal Medicine
1. Weight Loss May Not Help Prevent Progression of Knee Osteoarthritis With Varus Alignment
  A study shows that obesity is a risk factor for incident knee osteoarthritis but that there is no overall relationship between obesity and the progression of knee osteoarthritis. Medscape Medical News
Category:   Articles > Internal Medicine


2. Seizures Uncommon in Patients With Alzheimer Disease
  Although seizures are more likely in patients with Alzheimer disease (AD) than in the general population, they are not a common feature of AD, according to a paper in the August issue of the Archives of Neurology. Reuters Health Information
Category:   Articles > Internal Medicine


3. Antibiotics Not Useful for Acute Bronchitis in Immunocompromised Patients
  Even individuals with compromised immunity do not require antibiotics for acute bronchitis, according a paper in the November 8th issue of Thorax. Reuters Health Information
Category:   Articles > Internal Medicine


4. FDA Approvals: Fanapt and Cycloset
  The FDA has approved iloperidone tablets (Fanapt) and bromocriptine mesylate quick-release tablets (Cycloset). Medscape Medical News
Category:   Articles > Internal Medicine


5. Vinflunine, Docetaxel Comparable as Second-Line Therapy for Lung Cancer
  Vinflunine and docetaxel show similar efficacy as second-line agents for advanced non-small-cell lung cancer (NSCLC), researchers reported online March 29 in the Journal of Clinical Oncology. Reuters Health Information
Category:   Articles > Internal Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS